Eron, J. J., Clotet, B., Durant, J., Katlama, C., Kumar, P., Lazzarin, A., . . . Hawkins, T. (2013). Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study. Oxford University Press.
Chicago Stili AlıntıEron, Joseph J., et al. Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study. Oxford University Press, 2013.
MLA AlıntıEron, Joseph J., et al. Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study. Oxford University Press, 2013.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..